The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
225 jobs Number of planned job losses
Announcement Date
25 April 2013
Employment effect (start)
Foreseen end date
31 December 2013
Description
US-based pharmaceutical Eli Lily will make 225 people redundant with the closure of its site in Gießen (Hesse). As announced by a spokesperson, the closure is due to a challenging environment, overcapacities and terminating patents. The company announced talks with worker representatives.
Another 1,000 jobs will be axed in the USA, as announced in April. Eli Lily has a global workforce of 38,000 people.
Sources
25 April 2013: Gießener Allgemeine (Online)
Citation
Eurofound (2013), Eli Lilly, Closure in Germany, factsheet number 75318, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/75318.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
